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The yeast exosome and human
PM–Scl are related complexes
of 3* fi 5* exonucleases
Christine Allmang,1 Elisabeth Petfalski,1 Alexandre Podtelejnikov,2 Matthias Mann,2
David Tollervey,1,3 and Philip Mitchell1
1Institute of Cell and Molecular Biology, University of Edinburgh, Edinburgh EH9 3JR UK; 2CEBI Odense University,
DK-5230 Odense M, Denmark
We previously identified a complex of 3* fi 5* exoribonucleases, designated the exosome, that is expected to
play a major role in diverse RNA processing and degradation pathways. Further biochemical and genetic
analyses have revealed six novel components of the complex. Therefore, the complex contains 11 components,
10 of which are predicted to be 3* fi 5* exoribonucleases on the basis of sequence homology. Human
homologs were identified for 9 of the 11 yeast exosome components, three of which complement mutations in
the respective yeast genes. Two of the newly identified exosome components are homologous to known
components of the PM–Scl particle, a multisubunit complex recognized by autoimmune sera of patients
suffering from polymyositis–scleroderma overlap syndrome. We demonstrate that the homolog of the Rrp4p
exosome subunit is also a component of the PM–Scl complex, thereby providing compelling evidence that the
yeast exosome and human PM–Scl complexes are functionally equivalent. The two complexes are similar in
size, and biochemical fractionation and indirect immunofluorescence experiments show that, in both yeast
and humans, nuclear and cytoplasmic forms of the complex exist that differ only by the presence of the
Rrp6p/PM–Scl100 subunit exclusively in the nuclear complex.
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The RRP4 gene was identified initially in the yeast Sac-
charomyces cerevisiae, via a mutation that resulted in
defective pre-rRNA processing (Mitchell et al. 1996). Bio-
chemical analyses revealed that Rrp4p is a component of
a protein complex that was designated the exosome
(Mitchell et al. 1997). Initial characterization identified
five components of the exosome; Rrp4p, Rrp41p (Ski6p),
Rrp42p, Rrp43p, and Rrp44p (Dis3p). Of these, recombi-
nant Rrp4p, Rrp41p, and Rrp44p were each demonstrated
to have 38 fi 58 exonuclease activity in vitro (Mitchell et
al. 1997). The in vitro activities shown by the recombi-
nant proteins were not, however, identical. Rrp4p is a
distributive, hydrolytic enzyme, Rrp44p is a processive,
hydrolytic enzyme, and Rrp41p is a processive, phospho-
rolytic enzyme. Consistent with this activity, Rrp44p is
homologous to Escherichia coli RNase R (vacB), a mem-
ber of the RNase II family of processive, hydrolytic exo-
nucleases (Cheng et al. 1998), whereas Rrp41p is ho-
mologous to E. coli RNase PH, a phosphorolytic exo-
nuclease (Mian 1997; Mitchell et al. 1997). Rrp42p and
Rrp43p are also homologous to RNase PH (Mian 1997;
Mitchell et al. 1997), and, therefore, the five initial mem-
bers of the complex were all known or strongly predicted
to be 38 fi 58 exonucleases. It was, however, notable that
the purified exosome complex exhibited only a distribu-
tive, hydrolytic activity in vitro; no processive or phos-
phorolytic activities were observed (Mitchell et al. 1996,
1997). This observation suggested that a reason for the
assembly of multiple activities into one complex might
be to allow their coordinate repression in the absence of
activation by specific cofactors.
In all eukaryotes, the mature 5.8S, 18S, 25S/28S
rRNAs are generated from a single large pre-rRNA by
post-transcriptional processing. The five components of
the exosome that were identified initially were all
shown to be required for the 38 processing of the 7S pre-
rRNA to the mature 5.8S rRNA; genetic depletion of
each gave a very similar processing defect, which closely
resembled that seen in the original rrp4-1 mutation
(Mitchell et al. 1996, 1997). Subsequent analyses re-
vealed that the exosome functions not only as an RNA
processing complex but is also required for specific RNA
turnover pathways. The degradation of the excised
spacer fragment extending from the 58 end of the 35S
primary transcript to cleavage site A0 within the 58 ex-
ternal transcribed spacer (58 ETS) region is defective in
the rrp4-1 strain and in strains depleted of Rrp4p,
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Rrp41p, Rrp42p, Rrp43p, or Rrp44p (de la Cruz et al.
1998). A wider role for the exosome in RNA metabolism
was revealed by analyses that showed that Rrp4p and
Rrp41p (Ski6p) both function in the 38 fi 58 pathway of
mRNA degradation (Anderson and Parker 1998). From
these observations, the exosome complex, or related
complexes, were predicted to be present in both the
nucleolus and the cytoplasm.
Expression of the human homolog of Rrp4p, hRrp4p, in
yeast was shown to complement a rrp4-1 mutation and
glycerol gradient centrifugation indicated that hRrp4p
was present in HeLa cell lysates in a complex of similar
size to the yeast exosome (Mitchell et al. 1997). These
data suggested that a complex homologous to the exo-
some was present in human cells.
A large number of human autoimmune diseases have
been identified. Some of these, notably scleroderma, are
associated with the development of antibodies directed
against nucleolar epitopes (for review, see Reimer 1990).
In a relatively rare autoimmune disease, polymyositis–
scleroderma overlap syndrome (Reimer et al. 1986), pa-
tients frequently develop antibodies directed against a
100-kD protein, PM–Scl100 (Bluthner and Bautz 1992;
Ge et al. 1992). Less frequently another protein, PM–
Scl75 (Alderuccio et al. 1991), is also targeted. These two
proteins are components of a large complex, designated
the PM–Scl complex, that was estimated to have be-
tween 11 (Reimer et al. 1986) and 16 (Gelpi et al. 1990)
components. Interestingly, PM–Scl100 is homologous to
the E. coli 38 fi 58 exoribonuclease, RNase D (Briggs et al.
1998), whereas PM–Scl75 shows homology to RNase PH
(Mian 1997).
Here, we report the identification of six new compo-
nents of the yeast exosome and characterize distinct
nuclear and cytoplasmic forms of this complex. Two of
the newly defined exosome subunits are homologous to
the human PM–Scl100 and PM–Scl75 autoantigens, and
these proteins are associated with the human homolog of
another exosome component. Moreover, like the yeast
exosome, related human complexes are localized in
nucleus and cytoplasm. Together, these data provide
strong evidence that the PM–Scl complex is directly ho-
mologous to the yeast exosome.
Results
Identification of new components
of the exosome complex
The initial characterization of components that copre-
cipitated with protein A-tagged Rrp4p (ProtA–Rrp4p)
identified four proteins (Mitchell et al. 1997). Three of
these proteins, Rrp41p, Rrp42p, and Rrp43p, were ho-
mologous to E. coli RNase PH. However, the yeast ge-
nome contains three other putative open reading frames
(ORFs) with homology to RNase PH; YDR280w (RRP45),
YGR095c (RRP46; Mian 1997), and YGR158c (MTR3).
The RRP45 and RRP46 ORFs were each precisely deleted
in diploid strains of yeast (see Materials and Methods).
On sporulation of each diploid, only two viable spores
were recovered per tetrad and in each case the viable
spores carried the wild-type allele. We conclude that
RRP45 and RRP46 are both essential, at least for spore
viability. Conditional alleles were constructed by plac-
ing RRP45 and RRP46 under the control of a repressible
GAL10 promoter (see Materials and Methods). In each
case, the strains formed only microcolonies on solid me-
dium containing 2% glucose (data not shown) and ceased
growth following transfer from liquid RSG (raffinose/su-
crose/galactose) medium to liquid glucose medium (Fig.
1). We conclude that Rrp45p and Rrp46p are essential for
viability.
The strains depleted of Rrp45p or Rrp46p showed an
accumulation of 38 extended forms of the 5.8S rRNA that
extended in a ladder to the size of the 7S pre-rRNA but
not beyond (Fig. 2). This phenotype is essentially identi-
cal to that seen in strains depleted for Rrp4p (Fig. 2a) or
the four other components of the exosome identified pre-
viously (Mitchell et al. 1997). Mtr3p is essential for vi-
ability (Kadowaki et al. 1995), and a strain carrying a
temperature-sensitive lethal mtr3-1 allele (generously
provided by A.M. Tartakoff, Case Western Reserve Uni-
versity, Cleveland, OH) was analyzed. This strain also
accumulated 38 extended forms of the 5.8S rRNA after
transfer to the nonpermissive temperature (37°C; Fig.
2a). The mtr3-1 strain rapidly ceases growth following
transfer to 37°C, and little pre-rRNA was recovered at
the 24 hr time point, presumably because of the very low
growth rate. In addition, the strains depleted of Rrp4p,
Rrp45p, or Rrp46p or carrying mtr3-1 each accumulated
the excised 58 ETS region of the pre-rRNA, extending
from the 58 end of the primary transcript to cleavage site
Figure 1. The newly identified components of the exosome
complex are required for viability. Growth curves of GAL-regu-
lated constructs following transfer to glucose medium. Strains
were pregrown in permissive, RSG medium and transferred to
repressive, glucose medium for the times indicated. Strains
were maintained in exponential growth by dilution with pre-
warmed medium. Cell densities measured by OD600 are shown
corrected for dilution. (L) Wild type; (s) GAL::rrp45; (h)
GAL::rrp46; (l) GAL:csl4; (j) GAL::rrp40.
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A0 (Fig. 2c; 58 ETS), as well as degradation intermediates
(see also de la Cruz et al. 1998). We conclude that the
RNase PH homologs Rrp45p, Rrp46p, and Mtr3p are
each required for the function of the exosome complex.
These observations prompted us to re-examine the
biochemical purification of the exosome complex. A
whole-cell extract from a strain expressing ProtA–Rrp4p
under the control of the endogenous RRP4 promoter
from a low-copy-number CEN plasmid (Mitchell et al.
1997) was passed over an IgG–Sepharose column, and
proteins were eluted from the bound IgG–ProtA–Rrp4p
complex by use of a gradient of Mg2+ (Go¨rlich et al.
1996). Proteins were separated by SDS-PAGE, and bands
were excised and subjected to sequencing analysis by
mass spectroscopy (see Kuster and Mann 1998;
Shevchenko et al. 1996). Most bands were identified by
high mass accuracy peptide mass mapping as described
by Jensen et al. (1996). Several of the bands contained
more than one gene product that were, however, identi-
fied without recourse to mass spectrometric peptide se-
quencing. In these cases, an iterative approach was used.
First all tryptic peptide masses were searched against a
comprehensive protein database, identifying one yeast
protein. The peptide masses remaining after detailed
comparison of the spectrum against the found sequence
(second pass search), were again searched in the database,
yielding another yeast protein. In some cases MALDI
peptide mapping did not unequivocally identify the com-
ponents in a band. In these cases, nanoelectrospray on a
novel quadrupole Time of Flight instrument was per-
formed (Shevchenko et al. 1997a; Wilm et al. 1996). Two
broad peaks of eluted proteins were observed; Rrp44p
eluted at around 500 mM MgCl2 (Fig. 3A, lanes 4–6)
whereas Rrp41p, Rrp42p, Rrp43p, Rrp45p, Rrp46p, and
Mtr3p coeluted at around 1.6–1.8 M MgCl2 (Fig. 3A, lanes
16–18). Two other proteins observed in the 1.6–1.8 M
MgCl2 fractions were identified as Rrp6p (YOR001w)
and Rrp40p (YOL142w). The coelution of these compo-
nents supports their presence in a single complex.
ProtA–Rrp4p was eluted only in the acid wash of the
column (Fig. 3A, lane HAc).
Following immunoprecipitation of ProtA–Rrp4p, all of
the components were recovered with apparent stoichi-
ometry, with the exception of Rrp6p, which was esti-
mated from Coomassie staining to be approximately
fivefold less abundant than the other components (data
not shown). Because Rrp6p was eluted only at 1.6–1.8 M
MgCl2, along with most other exosome components, it
seemed unlikely that this low abundance was due to a
weaker association with the exosome complex. There-
fore, Rrp6p might be associated with only a subfraction
of the exosome complex. To test this model, a whole-cell
Figure 2. The newly identified compo-
nents of the exosome complex are required
for pre-rRNA processing. Northern analysis
of processing of the 5.8S and degradation of
the 58ETS region of the pre-rRNA in exo-
some mutants. RNA was extracted from
strains carrying GAL-regulated constructs
following transfer from permissive, RSG
medium to repressive, glucose medium for
the times indicated, or from the mtr3-1
strain following transfer from 25°C to 37°C
for the times indicated. RNA was separated
on an 6% polyacrylamide gel and hybrid-
ized with: (a) oligonucleotide 020 (comple-
mentary to the 5.8S/ITS2 boundary), (b) oli-
gonucleotide 017 (hybridizing to the mature
5.8S rRNA), (c) oligonucleotide 033 (hybrid-
izing to the 58ETS around position +278). (d)
oligonucleotide 041 (hybridizing to the 5S
rRNA). The position of migration of the pre-
rRNA species is indicated. The species la-
beled 58 ETS extends from the transcription
start site to site A0 (+610). Also shown is a
cartoon of the rDNA (not to scale) with the
mature rRNA regions as rectangles and the
transcribed spacers as lines. The 18S, 5.8S,
and 25S rRNAs are cotranscribed, separated
by the internal transcribed spacers (ITS1
and ITS2) and flanked by the external tran-
scribed spacers (58ETS and 38ETS). The 5S
rRNA is independently transcribed in the
opposite direction. The mature 5.8S rRNA is synthesized from the 7S pre-rRNA, which is 38 extended to site C2 in ITS2. The 58 end
of the 5.8S rRNA is generated by processing at sites at B1L and B1S, which lie about 8 nucleotides apart, generating 5.8SL and 5.8SS,
respectively. Because this event precedes 38 processing, the 7S, 6S, and 5.8S + 30 pre-rRNAs all show 58 heterogeneity, generating, e.g.,
6SL and 6SS.
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extract from the ProtA–Rrp4p strain was fractionated by
column chromatography (see Fig. 3B). Three fractions
containing ProtA–Rrp4p were recovered (Fig. 3C). The
most abundant complex was recovered in fraction 1; this
complex probably corresponds to the major complex pu-
rified previously by glycerol gradient centrifugation and
immunoprecipitation (Mitchell et al. 1997). In addition
to the previously characterized components of the exo-
some, fraction 1 contained Rrp40p, Rrp46p, and Mtr3p.
Other protein bands in fraction 1 were identified as
Csl4p (YNL232w) and the cytoplasmic Hsp70-like pro-
tein Ssa1p (YAL005c), but Rrp6p was not present. Frac-
tion 3 contained the same exosome components as frac-
tion 1, but lacked Ssa1p and contained Rrp6p. Rrp43p,
which comigrates with ProtA–Rrp4p and the IgG heavy
chain (Mitchell et al. 1997), was identified in fraction 3
but not in fraction 1 (Fig. 3C). Csl4p and Rrp45p also
appear to comigrate in SDS-PAGE; from the band
marked Csl4p + Rrp45p, only Rrp45p was identified
from the preparation shown in Figure 3A, whereas only
Csl4p was identified from the preparations shown in Fig-
ure 3C. It is, however, very likely that Rrp43p and
Rrp45p are components of both complexes (see also be-
low). Consistent with the recovery of Rrp6p in the total
immunoprecipitate (Fig. 3A), approximately threefold
less ProtA–Rrp4p was recovered in fraction 3 than in
fraction 1 (twofold less of the material recovered in frac-
tion 1 was loaded onto the gel in Fig. 3C than of the
material in fractions 2 and 3). Fraction 2 comprises only
ProtA–Rrp4p with Ssa1p, and was approximately four-
fold less abundant than fraction 1. Consistent with glyc-
erol gradient centrifugation (Mitchell et al. 1997), no free
ProtA–Rrp4p was recovered. The ProtA–Rrp4p–Ssa1p
complex was detected in variable yield on glycerol gra-
dients (typically 5%–10% of total ProtA–Rrp4p; Mitchell
et al. 1997) and may be due to dissociation of ProtA–
Rrp4p from the complex during purification, possibly re-
lated to the presence of the protein A tag.
CSL4 was identified previously in a screen for syn-
thetic lethality with the chromatin protein Cep1p and is
essential for viability (Baker et al. 1998). Conditional al-
leles of CSL4 and RRP40 were constructed by placing
their expression under the control of a GAL10 promoter
(see Materials and Methods). In each case, the strains
formed only microcolonies on solid medium containing
2% glucose (data not shown). Following transfer from
liquid RSG medium to liquid glucose medium (Fig. 1) the
strains ceased growth and 38 extended forms of the 5.8S
rRNA accumulated (Fig. 2a), showing a pattern of inter-
mediates similar to other exosome mutants. Depletion
of Rrp40p or Csl4p also led to the accumulation of the 58
ETS pre-rRNA spacer fragment (Fig. 2c). Therefore, ge-
netic depletion of any of the 10 essential components
identified by copurification results in very similar de-
fects in the processing of the 5.8S rRNA, showing that
they form a single complex.
RRP6 is not essential for viability (Briggs et al. 1998),
and a strain carrying a precise deletion of RRP6 was con-
structed (see Materials and Methods). This strain was
impaired in growth at all temperatures and was nonvi-
able at 37°C (temperature-sensitive lethal; data not
shown). The rrp6-D strain was defective in the 38 pro-
cessing of the 5.8S rRNA, but differed from the other
Figure 3. Fractionation of the exosome complex and identifi-
cation of new components. (A) Proteins associated with IgG–
Sepharose via binding to ProtA–Rrp4p were eluted using a gra-
dient of MgCl2 and analyzed by SDS-PAGE. (Lanes 1–20) Mate-
rial eluted with a 100 mM step gradient of MgCl2 concentration
from 100 mM (lane 1) to 2 M (lane 20). (HAc) Proteins eluted by
the acid wash. Proteins are visualized by silver staining. The
strong bands specifically seen in lane 8 were not observed in
other experiments. (B) Purification scheme. A whole-cell ex-
tract (CXT) was batch-bound to DEAE–Sepharose FF. Bound
material was eluted (E300) with TMN buffer containing 300 mM
NaCl/10% glycerol (TMN-300). The eluate, in TMN-100, was
passed through a Mono Q column and bound material was
eluted stepwise with TMN-150, TMN-200 (E200), TMN-320
(E320), and TMN-500. Material that failed to bind to DEAE–
Sepharose FF (FT) was passed through a Mono S column and
bound material was eluted with TMN-500 (E500). Each sample
was immunoprecipitated on IgG–Sepharose. (C) Proteins pre-
sent in fractions 1, 2, and 3, obtained as outlined in B, were
separated by SDS-PAGE. Approximately twofold more of the
material recovered in fractions 2 and 3 was loaded onto the gel,
as compared with fraction 1. Proteins positively identified by
mass spectroscopy are indicated. Species in brackets were not
identified in the preparations shown but are predicted to be
present from other analyses. Molecular weight markers are also
shown. Proteins are visualized by Coomassie staining.
PM–Scl and the exosome
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components of the exosome insofar as it accumulated a
discrete species, 5.8S + 30, that was 38 extended by ~ 30
nucleotides (Fig. 2a; Briggs et al. 1998). The rrp6-D strain
also accumulated the 58 ETS region of the pre-rRNA (Fig.
2c). We conclude that the exosome includes at least 11
components, all of which are required for normal 38 pro-
cessing of the 5.8S rRNA and degradation of the 58 ETS
region. Ten of these are essential for viability, whereas
the absence of Rrp6p results in temperature-sensitive le-
thality (see Table 1).
It is unclear whether Ssa1p is a genuine component of
the complex or associates with the exosome as a conse-
quence of the protein A tag present on Rrp4p. In either
event, because Ssa1p is predominantly cytoplasmic
(Chirico et al. 1988; Deshaies et al. 1988), one obvious
possibility was that fractions 1 and 3 contained cytoplas-
mic and nuclear forms of the exosome, respectively. To
test this possibility, a ProtA–Rrp6p fusion was con-
structed (see Materials and Methods). The ProtA–Rrp6p
construct complemented the temperature-sensitive le-
thal growth phenotype of the rrp6-D mutation, largely
suppressed the accumulation of the 5.8S + 30 species in
this strain, and cosedimented with ProtA–Rrp4p through
glycerol gradients (data not shown). Therefore, we con-
clude that the protein A epitope does not grossly impair
the ability of Rrp6p to associate with the exosome or to
function in the cell.
Immunolocalization of the ProtA–Rrp6p and ProtA–
Rrp4p (Mitchell et al. 1996) fusion proteins was com-
pared to the nucleolar marker ProtA–Nop1p (Grandi et
al. 1993) and staining of the nucleoplasm with DAPI.
ProtA–Rrp6p gave a nuclear signal, with nucleolar en-
richment and a punctate nucleoplasmic staining. ProtA–
Rrp4p was also observed in the nucleoplasm and nucleo-
lus, but was additionally detected in the cytoplasm (Fig.
4). Notably, a GFP–Rrp43p fusion protein has recently
been reported to be localized to both the nucleus and
cytoplasm (Zanchin and Goldfarb 1999).
We conclude that two major forms of the exosome can
be purified that contain at least 10 common compo-
nents, Rrp4p, Rrp40–Rrp46p, Mtr3p, and Csl4p, all of
which are essential for viability and are required for exo-
some function. Rrp6p is present only in a subfraction of
the complex that is confined to the nucleus.
Characterization of the human PM–Scl complex
Rrp6p shows substantial homology to the human protein
PM–Scl100 (Briggs et al. 1998), whereas Rrp45p is ho-
mologous to PM–Scl75 (Mian 1997), both of which are
targets of autoimmune antibodies in patients suffering
from polymyositis–scleroderma overlap syndrome (Al-
deruccio et al. 1991; Bluthner and Bautz 1992; Ge et al.
1992). Moreover, human orthologs have been identified
for the Rrp4p, Rrp44p and Csl4p components of the exo-
some (Mitchell et al. 1997; Baker et al. 1998; Shiomi et
al. 1998). Strikingly, expression of each of these cDNAs
can suppress the phenotypes of mutations in the corre-
sponding yeast genes, demonstrating their functional
conservation (Mitchell et al. 1997; Baker et al. 1998;
Shiomi et al. 1998). Translational searches of the human
EST banks (see Materials and Methods) allowed virtual
cDNAs to be assembled for hRrp40p, hRrp41p, hRrp42p,
and hRrp46p; in each case, the putative human protein










Rrp40p YOL142w essential S1 RNA BD hRrp40p
35% (48%)
homologous to Rrp4p
Rrp41p/Ski6p YGR195w essential RNase PH hRrp41p
35% (55%)
Rrp42p YDL111c essential RNase PH hRrp42p
25% (51%)
Rrp43p YCR035c essential RNase PH
Rrp45p YDR280w essential RNase PH PM-Scl75
38% (64%)
human KIAA0116 and OIP2
also homologous
Rrp46p YGR095c essential RNase PH hRrp46p
35% (48%)
Mtr3p YGR158c essential RNase PH
Rrp44p/Dis3p YOL021c essential RNase R hDis3p hDis3p complements
(RNase II family) 45% dis3-81




Rrp6p YOR001w ts lethal RNase D PM-Scl100
32% (52%)
component only of nuclear complex
Rrp4p, Rrp40p, and Cs14p are not clearly homologous to known exonucleases from E. coli but are predicted to include regions
homologous to the S1 RNA-binding domain (S1 RNA BD). For the human homologs numbers represent the percentage identity
(similarity). In the case of Cs14p (Baker et al. 1998), Rrp40p, Rrp41p, Rrp42p, and Rrp46p, the numbers are based on consensus cDNAs
assembled from ESTs and may not be fully accurate. (See text for references.)
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showed high homology to the yeast protein (Table 1). In
addition, two other genes, KIAA0116 and OIP2, were
found to be homologous to Rrp45p, although less so than
PM–Scl75. For hRrp40p and hRrp46p, apparent products
of alternative splicing were evident when the EST se-
quences were assembled into contigs (data not shown).
In some cases, these alternative forms may have led to an
overestimation of the number of discrete protein species
in the PM–Scl complex.
Previous analyses showed that hRrp4p is present in a
large complex (Mitchell et al. 1997). To determine
whether the human homologs of other exosome compo-
nents are present in the same complex, HeLa cell nuclear
and cytoplasmic extracts (generously provided by Juan
Valca´rcel, EMBL, or prepared as described in Materials
and Methods) were fractionated by glycerol gradient cen-
trifugation. Fractions were analyzed by Western blotting
with human autoimmune serum (generously provided
by Walter van Venrooij, University of Nijmegen, The
Netherlands) or antibodies raised against recombinant
hRrp4p (Mitchell et al. 1997; Fig. 5). In the nuclear ex-
tract, PM–Scl75 and an uncharacterized protein of ~ 25
kD that is also a target of the autoimmune serum (PM–
Scl25) cosedimented with hRrp4p, with a peak in frac-
tions 13 and 14. PM–Scl100 also showed substantial
cosedimentation (Fig. 5A). The band at 45 kD is likely to
be the species previously reported to cross-react with
anti-PM–Scl75 antibodies (Alderuccio et al. 1991). PM–
Scl100 was not detected in the cytoplasmic extract, but
PM–Scl75 and hRrp4p cosedimented (Fig. 5B), as did
PM–Scl25 (data not shown), with a peak in fractions 13
and 14.
To confirm the association between PM–Scl100 and
hRrp4p in the HeLa cell nuclear extract, immunoprecipi-
tation was performed (Fig. 6). Three different autoim-
mune sera (sera 1–3) were used, each of which reacted
Figure 4. Rrp4p and Rrp6p differ in their nuclear-cytoplasmic
distribution. (A) Strains expressing ProtA–Rrp4p, ProtA–Rrp6p,
or ProtA–Nop1p were examined by indirect immunofluores-
cence using an anti-protein A antibody coupled to Texas Red.
Also shown is the position of the DNA, visualized by DAPI
staining. The combined image is pseudocolored with DAPI in
green and Texas Red in red. For each tagged strain an otherwise
isogenic wild-type control strain was also analyzed. The wild-
type strain shown (P51) is isogenic with the ProtA–Rrp4p strain
(see Table 2). (B) Higher resolution images are shown for the
ProtA–Rrp4p and ProtA–Rrp6p to show the punctate staining
pattern.
Figure 5. Cosedimentation of hRrp4p and the PM–Scl com-
plex. (A) HeLa cell nuclear extract. (B) HeLa cell cytoplasmic
extract. Cell extracts were fractionated by glycerol gradient cen-
trifugation. Samples were analyzed by Western blotting deco-
rated with human autoimmune antisera reactive against PM–
Scl100, PM–Scl75, and a previously uncharacterized human
protein (PM–Scl25) or with rabbit antiserum raised against re-
combinant hRrp4p. The serum also cross-reacts with an unre-
lated 45-kD protein. Also shown is the sedimentation of mo-
lecular weight markers on a gradient run in parallel with the
nuclear extract. Markers: (A) alcohol deyhdrogenase from yeast
(7.4S); (B) bovine serum albumin (4.3S); (C) bovine catalase
(11.3S; Siegel and Monty 1966).
PM–Scl and the exosome
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specifically with PM–Scl100 on Western blots of the to-
tal nuclear extract (Fig. 6B). Following immunoprecipi-
tation, hRrp4p was recovered in the immune precipitate
(P) with each PM–Scl100 serum (Fig. 6A), but was not
coprecipitated with a control human serum. In contrast,
another human nucleolar protein, hPop1p, a component
of RNase mitochondrial RNA processing (MRP) (Lygerou
et al. 1996), was recovered exclusively in the immune
supernatant (S; Fig. 6A). We conclude that hRrp4p is as-
sociated physically with PM–Scl100 in a human nuclear
extract. The efficiency of precipitation of PM–Scl100 and
PM–Scl75 could not be assessed in this experiment, be-
cause the secondary, anti-human antibody reacted very
strongly with the human antibodies present in the im-
munoprecipitate.
The subcellular localization of the PM–Scl complex
was assessed by nuclear–cytoplasmic fractionation.
Western blotting (Fig. 6C) showed that PM–Scl75 and
hRrp4p were partitioned between the nuclear and cyto-
plasmic fractions. In contrast, PM–Scl100 was detected
exclusively in the nuclear fraction (Fig. 6B,C). Rabbit an-
tibodies directed against actin (Sigma A2066) decorated a
band exclusively in the cytoplasmic fraction (Fig. 6C).
Approximately equal quantities of PM–Scl75 and hRrp4p
were recovered in the cytoplasmic and the nuclear frac-
tions. Only very low amounts of PM–Scl100, PM–Scl75,
and hRrp4p were detected in the residual nuclear pellet
(data not shown).
We conclude that there are at least two forms of the
human PM–Scl complex: a nuclear complex that in-
cludes PM–Scl100 and a cytoplasmic complex that lacks
PM–Scl100. These are very likely to be directly equiva-
lent to the nuclear and cytoplasmic forms of the yeast
exosome, that similarly differ by the presence of Rrp6p,
the yeast homolog of PM–Scl100, only in the nuclear
complex.
Discussion
Here, we report the identification of 11 components of
the nuclear exosome complex (Table 1). Remarkably, six
of the components are homologous to E. coli RNase PH;
Rrp41p, Rrp42p, Rrp43p, Rrp45p, Rrp46p, and Mtr3p. Of
the remaining exosome components, Rrp6p is homolo-
gous to E. coli RNase D (Briggs et al. 1998), and Rrp44p
is homologous to E. coli RNase R/vacB (Mitchell et al.
1997), an RNase II family member (Cheng et al. 1998).
Rrp40p shows homology to Rrp4p, which was shown
previously to be a 38 fi 58 exonuclease in vitro (Mitchell
et al. 1997), and, therefore, Rrp40p is also predicted to be
an exonuclease. The only component of the exosome
complex that does not show homology to a known exo-
nuclease is Csl4p. It is, however, notable that both yeast
Csl4p and human hCsl4p include sequences homologous
to the S1 RNA-binding domain (Bycroft et al. 1997; S.
Mian, pers. comm.), strongly indicating that it too inter-
acts directly with RNA substrates. Rrp4p and Rrp40p are
also predicted to contain S1 RNA-binding domains (S.
Mian, pers. comm.).
We previously identified the human homolog of Rrp4p
and showed that expression of the hRRP4 cDNA in yeast
could suppress the temperature-sensitive lethality of the
rrp4-1 allele (Mitchell et al. 1997). Subsequently, the
cDNA encoding the human homolog of Rrp44p/Dis3p
has been shown to partially complement a temperature-
sensitive lethal dis3 allele (Shiomi et al. 1998), and the
cDNA encoding hCsl4p has been shown to complement
the synthetic-lethal phenotype of a csl4-1, cep1-D double
mutant strain (Baker et al. 1998). Sequence comparisons
indicate that human homologs exist for 9 of the compo-
nents of the yeast exosome complex (see Table 1). Nota-
bly, Rrp6p is homologous to PM–Scl100 (Briggs et al.
1998) whereas Rrp45p is homologous to PM–Scl75. Both
of these proteins are the targets of autoimmune antibod-
ies in human patients suffering from polymyositis–
scleroderma overlap syndrome (Alderuccio et al. 1991;
Ge et al. 1992). The PM–Scl complex was reported to
contain between 11 (Reimer et al. 1986) and 16 (Gelpi et
al. 1990) proteins, as judged by SDS-PAGE analysis of
immunoprecipitated proteins. We have shown by copre-
cipitation that hRrp4p is associated with PM–Scl100 in
HeLa cell nuclear extracts, and hRrp4p cosedimented
Figure 6. Characterization of the PM–Scl complex. (A) Three
different human autoimmune sera with specificity for PM–
Scl100 were used for immunoprecipitation from a HeLa nuclear
extract. The total HeLa nuclear extract, supernatant (S), and
pellet (P) fraction are shown. Each lane represents an equivalent
quantity of lysate. Western blots were decorated with rabbit
sera raised against recombinant hRrp4p or hPop1p, a compo-
nent of the RNase MRP complex. (B) Western blots of total
HeLa nuclear (N) and cytoplasmic (C) extracts decorated with
the anti-PM–Scl100 sera used for immunoprecipitation, demon-
strating the specificity of the sera. (C) Western blots of total
HeLa nuclear (N) and cytoplasmic (C) extracts decorated with
rabbit sera raised against recombinant hRrp4p or human actin,
or with a human autoimmune serum reactive against both PM–
Scl100 and PM–Scl75. Cell equivalent volumes of the nuclear
and cytoplasmic fractions were loaded.
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with PM–Scl75 and PM–Scl25 in both nuclear and cyto-
plasmic extracts. Homologs of at least three components
of the exosome are present in the PM–Scl complex, pro-
viding strong evidence that these complexes are directly
homologous.
Six human homologs of RNase PH were identified.
These do not, however, have a 1:1 relationship with the
six RNase PH homologs in the exosome. No clear hu-
man homologs were identified for Rrp43p or Mtr3p.
Searches of the EST banks with these proteins identified
ESTs related to KIAA0116 and OIP2; these sequences
are, however, more homologous to Rrp45p than to the
other yeast PH homologs (although less so than PM–
Scl75). A probable interpretation is that yeast and hu-
mans have the same number of RNase PH homologs, but
that some drift has occurred with duplicates of the
RRP45/PM–Scl75 gene replacing other species.
Mutations in individual components of the yeast exo-
some inhibited both nucleolar pre-rRNA processing and
cytoplasmic mRNA turnover (Anderson and Parker
1998), indicating that related complexes are present in
the nucleus and the cytoplasm. Moreover, a mutation in
Mtr3p leads to nuclear accumulation of poly(A)+ RNA
(Kadowaki et al. 1995), as does a mutation in Dob1p/
Mtr4p (de la Cruz et al. 1998; Liang et al. 1996), a puta-
tive RNA helicase required in addition to the exosome
for 5.8S rRNA 38 end maturation and degradation of the
58 ETS fragment (de la Cruz et al. 1998). These observa-
tions suggest that the exosome may also play some role
in nucleoplasmic RNA turnover or processing. Consis-
tent with this hypothesis, GFP–Rrp43p (Zanchin and
Goldfarb 1999) and ProtA–Rrp4p were detected in the
nucleolus, nucleoplasm, and cytoplasm. In contrast,
ProtA–Rrp6p was found to be exclusively nuclear, with a
nucleolar enrichment. Two complexes could also be
separated biochemically; these include 10 common com-
ponents and differ in the presence of either Ssa1p, a cy-
toplasmic Hsp70-like protein (Chirico et al. 1988; De-
shaies et al. 1988), or Rrp6p. The form lacking Rrp6p is
presumed to be the cytoplasmic exosome complex, a pro-
posal supported by the presence of Ssa1p. Approximately
threefold more of this complex was recovered than the
putative nuclear exosome that includes Rrp6p. Human
PM–Scl100 was also restricted to the nucleus, while PM–
Scl75, PM–Scl25, and hRrp4p partition between the
nucleus and cytoplasm. The reported nucleolar enrich-
ment of the human PM–Scl complex is probably a con-
sequence of the immunodominance of PM–Scl100 in au-
toimmune sera (Ge et al. 1992; Gelpi et al. 1990). In fact,
approximately equal amounts of the human nuclear and
cytoplasmic complexes were recovered following subcel-
lular fractionation.
We conclude that there are two forms of the exosome/
PM–Scl complex in the nucleus and the cytoplasm that
can be distinguished by the presence of Rrp6p/PM–
Scl100 specifically in the nuclear form.
Rrp6p is not essential for viability, in contrast to the
other 10 components of the exosome complex, although
rrp6-D strains are severely impaired in growth and are
temperature sensitive. Therefore, the exosome is there-
fore predicted to retain at least partial function in the
absence of Rrp6p, a view supported by the observation
that the major form of the complex lacks this protein.
Conversely, all of the PM–Scl100 present in Hela cell
lysates appeared to be associated with the PM–Scl com-
plex, suggesting that Rrp6p/PM–Scl100 may not func-
tion independently of the complex in vivo.
In E. coli, the homologs of the exosome components
are not present in a related complex. However, the de-
gradosome complex includes another 38 fi 58 exonucle-
ase, PNPase, together with the endonuclease and exo-
nuclease RNase E and the putative RNA helicase RhlB
(Carpousis et al. 1994; Py et al. 1996; Mackie 1998;
Vanzo et al. 1998). It appears that throughout evolution,
major activities involved in RNA processing and degra-
dation have been assembled into large complexes, possi-
bly to allow their coordinate regulation. The composi-




Except where stated, strains were grown in liquid or on solid
minimal medium containing 0.67% yeast nitrogen base
(DIFCO) and 2% glucose with appropriate supplements. For
depletion, strains carrying GAL-regulated constructs were
pregrown in RSG (2% peptone, 1% yeast extract, 2% raffinose,
2% sucrose, 2% galactose) and transferred to YPD (2% peptone,
1% yeast extract, 2% glucose).
Yeast strains used and constructed in this study are listed in
Table 2. Gene disruptions of RRP45 and RRP46 were generated
by a PCR strategy in the diploid strain BMA38 (Baudin et al.
1993) resulting in the replacement of the complete ORF by an
auxotrophic marker (see Table 2). Successful disruption was
confirmed by Southern hybridization. Chromosomal DNA from
the RRP45/rrp45::TRP1 and RRP46/rrp46::HIS3 strains was di-
gested by EcoRI–HindIII or KpnI–EcoRI, respectively, and hy-
bridized with a probe derived from the PCR products that were
used for transformation. Twelve tetrads from the RRP45/
rrp45::TRP1 strain and eight tetrads from RRP46/rrp46::HIS3
strain were dissected on YPD plates and incubated for 6 days at
23°C. Each showed 2:2 segregation for spore viability. All viable
spores were auxotrophic for tryptophan or histidine, respec-
tively, indicating that the disrupted alleles were lethal. The
nonessential RRP6 gene was disrupted in the haploid strain
YBD38 (see Table 2) by use of the Kluyveromyces lactis TRP
marker, obtained by PCR amplification from plasmid pBS1408
(generously provided by Bertrand Se´raphin, EMBL, Heidelberg,
Germany).
The oligonucleotides used to construct and test the gene dis-
ruptions were 58RRP45::TRP1 (807); 38RRP45::TRP (808); 58
RRP46::HIS3 (809); 38RRP46::HIS3 (810); 58RRP6::Kl TRP (811);
38RRP6::Kl TRP (812). Test oligonucleotides were 38RRP45
(813); 38RRP6 (815); Sc TRP (816); HIS (817); Kl TRP (818) (full
sequences are available from the authors).
Conditional mutants under the control of the inducible
GAL10 promoter were generated for the RRP40, RRP45, RRP46,
and CSL4 genes by a one-step PCR strategy in the YDL401
strain (Lafontaine and Tollervey 1996). Transformants were se-
lected for His+ prototrophy and screened by PCR.
The oligonucleotides used to construct the conditional mu-
tants were 58GAL-RRP45 (819); 38GAL-RRP45 (820); 58GAL-
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RRP46 (821); 38GAL-RRP46 (822); 38GAL-ProtA–RRP46 (823);
58GAl-RRP40 (824); 38GAl-RRP40 (825); 58GAL-CSL4 (826);
38GAL-CSL4 (827). The amplification of RRP6::TRP was done
with oligonucleotides 58RRP6 (834) and 38RRP6 (835) (full se-
quences are available from the authors).
Construction of the ProtA–Rrp6p fusion
To construct the ProtA–RRP6 fusion gene, the RRP4 ORF was
excised from plasmid pPM46 (Mitchell et al. 1997) by restriction
cleavage at sites EcoRI and HindIII and replaced by the RRP6
ORF amplified by PCR from wild-type genomic DNA and
flanked by the same restriction sites. The resulting plasmid was
transformed into the haploid RRP6::TRP strain and shown to
complement fully the RNA processing and growth phenotypes
of the deleted strain. The oligonucleotides used for the PCR
were 58PRS (836) and 38PRS (837).
Fractionation of ProtA–Rrp4p complexes
Lysate from 5-liter YPD cultures of strain P49 was prepared in
TMN buffer [10 mM Tris-HCl (pH 7.6), 5 mM MgCl2, 0.1% NP-
40] containing 150 mM NaCl, 1 mM PMSF, and 10% glycerol, as
described (Mitchell et al. 1996). ProtA–Rrp4p complexes were
purified by immunoprecipitation with IgG–Sepharose, either
from clarified lysates or after fractionation by low-pressure col-
umn chromatography. Purification procedures were carried out
at 4°C in buffers containing 0.5 mM PMSF and fractions were
screened for the presence of ProtA–Rrp4p by Western blot analy-
ses, using peroxidase-antiperoxidase rabbit antibody (Sigma).
Cleared lysate was applied directly to a 100-µl IgG–Sepharose
6 FF column (Pharmacia) and washed with 100 ml of TMN-150,
bound material was eluted with a 0.1–2 M MgCl2 gradient
(Go¨rlich et al. 1996) in TMN-150 buffer (20 fractions of 150 µl at
increments of 100 mM MgCl2). Aliquots of 5 µl were resolved by
SDS-PAGE and visualized by silver staining. Fractions contain-
ing the proteins of interest were precipitated with 9 vol of iso-
propanol, pooled, and analyzed on 10% polyacrylamide gels
containing SDS.
For fractionation, cleared lysate (30 ml) diluted to 100 mM
NaCl was batch-bound to DEAE–Sepharose FF (Pharmacia).
Bound material was washed three times with 30 ml of TMN
buffer containing 100 mM NaCl (TMN-100), eluted with 5 × 30
ml TMN-300/10% glycerol (E300) and then frozen at −80°C.
The pooled eluates were diluted to 100 mM NaCl and passed
through a 10-ml Q-Sepharose FF column (Mono Q; Pharmacia).
Bound material was eluted stepwise with 50 ml of TMN-150,
TMN-200 (E200), TMN-320 (E320), and TMN-500. Material
that failed to bind to DEAE–Sepharose FF (FT) was passed
through a 10-ml SP–Sepharose FF column (Mono S; Pharmacia).
After washing with 50 ml of TMN-300, bound material was
eluted with 50 ml of TMN-500 (E500). Eluates from the Mono Q
and Mono S columns were diluted to 150 mM NaCl and passed
through small (100 µl) IgG–Sepharose 6 FF columns. Bound ma-
terial was washed with 100 ml of TMN-150, and retained pro-
teins were eluted with 1 ml of 0.5 M acetic acid. The eluates
were concentrated by centrifugation under vacuum and ana-
lyzed by SDS-PAGE and nanospray mass spectrometry, as
above.
Mass spectrometric analysis
Proteins bands were excised from the gel, digested in the gel,
and analyzed according to the strategy described elsewhere
(Shevchenko et al. 1996). High mass accuracy MALDI peptide
mapping (Jensen et al. 1996) was performed on a Bruker Reflex
III mass spectrometer (Bruker Daltonics, Bremen, Germany). To
resolve protein mixtures an iterative approach (Jensen et al.
1997) was used. In case of uncertainty identifications were con-
firmed by nanoelectrospray tandem mass spectrometry on a pi-
lot QqTOF instrument (SCIEX, Toronto, Canada; Shevchenko
et al. 1997b). PeptideSearch software, developed in house, was
used for protein database searching.
Glycerol gradient analysis of a HeLa cell extracts
HeLa cell lysates were prepared according to standard proce-
dures (Dignam et al. 1983; Lee et al. 1988). Nuclear and cyto-
plasmic extracts were centrifuged through 12-ml glycerol den-
sity gradients as described previously (Mitchell et al. 1997). Gra-
dient fractions were analyzed by Western blotting analysis with
rabbit anti-hRrp4p serum or sera of patients suffering from poly-
Table 2. Strains used in this study
Strain Genotype Reference/Note
BMA38 MATa/a ade2-1/ade2-1 his3-D200/his3-D200 leu2-3,112/leu2-3,112 trp1-1/trp1-1
ura3-1/ura3-1 can1-100/can1-100 Baudin et al. (1993)
YCA10 as BMA38 but RRP45/RRP45<TRP1 this study
YCA11 as BMA38 but RRP46/RRP46<HIS3 this study
YCA12 MATa ade2-1 his3-D200 leu2-3,112 trp1-1 ura3-1 can1-100 RRP6<Kl TRP1 this study
YTK100 MATa mtr3-1 ura3-52 Kadowaki et al. (1995)
YDL401 MATa his3D200 leu2D1 trp1 ura3-52 gal2 galD108 Lafontaine and
Tollervey (1996)
YCA20 as YDL401 but GAL10<RRP45 this study
YCA21 as YDL401 but GAL10<RRP46 this study
P79 as YDL401 but GAL10<protA–RRP4 Mitchell et al. (1997)
P147 as YDL401 but GAL10<RRP40 this study
P170 as YDL401 but GAL10<CSL4 this study
GAL<DOB1 MATa ura3-1 ade2-1 his3-11,15 leu2-3,112 trp1-1 dob1<HIS3MX6 + [pAS24–DOB1] de la Cruz et al. (1998)
P49 MATa ade2-1 his3-11 leu2-3 trp1-1 ura3-52 can1-100 rrp4D<HIS3 + [pRS416/protA–RRP4] Mitchell et al. (1996)
P51 MATa ade2-1 his3-11 leu2-3 trp1-1 ura3-52 can1-100 rrp4D<HIS3 + [pRS415/RRP4] Mitchell et al. (1996)
YCA40 MATa ade2-1 his3-D200 leu2-3,112, trp1-1 ura3-1 can1-100 RRP6<Kl TRP1 +
[pRS416/protA–RRP6] this study
ProtA–Nop1 MATa ade leu trp lys ura3 nop1<URA3 + [pUN100–protA–NOP1] Jansen et al. (1993)
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myositis–scleroderma overlap syndrome [kindly provided by
Dr. W. van Venrooij and obtained from the University Hospital
(St. Radboud) of Nijmegen].
Immunofluorescence
Cells were grown in selective medium to mid-exponential
phase, fixed by incubation in 4% (vol/vol) formaldehyde for 1 hr
at room temperature, and spheroplasted. Then immunofluores-
cence was then performed as described previously (Berge`s et al.
1994; Grandi et al. 1993). Protein A fusions were detected with
a rabbit anti-protein A antibody (Sigma) and a secondary goat
anti-rabbit antibody coupled to Texas Red (Dianova) at a 1:100
and 1:200 dilution, respectively. To stain nuclear DNA, DAPI
was included in the mounting medium (Vectashield, Vector
Laboratories).
Immunoprecipitation of the PM–Scl complex with
patient sera
Patient sera directed specifically against PM–Scl100 (kindly pro-
vided by Dr. W. van Venrooij) were used for the immunopre-
cipitation experiments. HeLa cell lysates were prepared as de-
scribed above. A 50% solution of protein A–Sepharose beads
(10µl; Pharmacia) was washed three times in IPP 500 [500 mM
NaCl, 10 mM Tris-HCl (pH 8), 0.1% NP-40, 0.5 mM PMSF] and
incubated for 1 hr at room temperature with 5 µl of human
autoimmune sera. Beads were washed three times with IPP500,
transferred in 10 µl of IPP150 ([50 mM NaCl, 10 mM Tris-HCl
(pH 8), 0.1% NP-40, 0.5 mM PMSF] and then added to 10 µl of
HeLa cell nuclear extract. After incubation for 2 hr at 4°C, the
supernatant was recovered and beads were washed four times
with IPP150. Bound proteins were eluted from the beads by a 5
min boiling in protein gel loading buffer. Total, supernatant,
and pellet proteins were analyzed by SDS-PAGE and Western
blotting analysis with anti-hRrp4p serum or affinity-purified
anti-hPop1 antibodies (Lygerou et al. 1996; Mitchell et al. 1997).
RNA analysis
RNA isolation and Northern blot hybridization were performed
as described previously (Beltrame and Tollervey 1992; Tollervey
1987). Oligonucleotides used for rRNA and pre-rRNA analysis
were 58-TGAGAAGGAAATGACGCT (oligonucleotide 020),
58-GCGTTGTTCATCGATGC (oligonucleotide 017), 58-CGC-
TGCTCACAATGG (oligonucleotide 033), and 58-CTACTCG-
GTCAGGCTC (oligonucleotide 014).
Database searches
The human EST banks were searched using the EFEAME p2n
program for translational frame-shifting, on the Bioaccelerator
of the European Molecular Biology Laboratory (http://ww-
w.embl-heidelberg.de). Contigs were assembled from the re-
trieved ESTs by use of the Gene JockeyII program. Homology
was calculated by use of using the Bestfit program [Wisconsin
Package Version 9.1, Genetics Computer Group (GCG), Madi-
son, WI.].
The ESTs used for the alignments were hRRP40: HS103148,
AA916866, AA715297, AA909843, AA829746, AA760696,
AA748308, AA747303, HSA01383, HS479237, HS417169,
HS1213865, HS1191331, HS1186630, AA937191, AA741488,
HSA57832, HSA01383, HS620247, HS617138, AA736510,
HS1300540, HS1273716, HS1269362, HS1229711, HS1198690,
HS1191331, and HS1174014; hRRP41: HS0229, HSZZ84720,
HS462881, HS1210855, HS060127, and HSAA29848; hRRP42:
AA654791, HS599371, HSZZ85135, HS20834, AA581010,
HS414162, HS979316, and HSZZ84357; hRRP46: HS078341,
HS84856, HS1255212, HS1226957, HSZZ41259, HS1256223,
HS1225454, HS1249336, and HS1172072.
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